AM BioTech - Ascension Medical Biotechnology

What AM BioTech - Ascension Medical Biotechnology does

AM BioTech is a Taipei-headquartered biotechnology company founded in December 2020 (originating from IRH Technology Co., Ltd., established 2015) that develops, manufactures, and commercializes patented Bio-Pulsed Exosome products for the cosmetics, medical aesthetics, and pharmaceutical industries. The company operates an integrated business model spanning four revenue streams: B2B sales of its flagship cosmetic raw material ingredient ExoGiov® (a lyophilized Bio-Pulsed exosome derived from SPF chicken embryonic mesenchymal cells with INCI certification); OEM/ODM contract manufacturing services for cosmetics brands; consumer-facing skincare and haircare products sold under the LA EXO® brand via its own e-commerce site and Taiwan's MOMO Shopping Network; and a newly launched pharmaceutical CDMO partnership with PITDC covering regenerative medicine applications including gynecology, orthopedics, ophthalmology, and wound healing. R&D and manufacturing are conducted at a PIC/S GMP-compliant facility in Neihu District equipped with Class 10,000 cleanrooms, and the technology has been granted patents in five jurisdictions (Taiwan, China, Japan, US, Korea). The company's Bio-Pulsed Activation Technology claims to induce stem-cell-derived exosomes with 1900x higher vesicle particle counts, 202% higher protein content, 188% higher miRNA content, 99.99% purity, and 2-year room-temperature shelf stability — performance attributes intended to overcome cold-chain logistics, regulatory restrictions on human-derived exosomes, and the limited efficacy of conventional naive exosome ingredients. Distribution is global, with active sales channels across Europe, the US (via Emosoxe Biotech International), China, Korea, Japan, and ASEAN (via TAITRA's Malaysia center), supported by a clinical validation network spanning Tri-Service General Hospital, National Taiwan University Hospital, and Taipei Veterans General Hospital, and by a 2024 Estée Lauder NIV BRKTHRU VOICES top-5 finalist recognition at In-Cosmetics Global.

Name

AM BioTech - Ascension Medical Biotechnology

Legal name

Ascension Medical Biotechnology Co., Ltd.

Website

https://en.ambiotech.asia

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

AM BioTech is a Taipei-based biotech that develops and manufactures patented Bio-Pulsed Exosome ingredients (ExoGiov®) and consumer skincare (LA EXO®) for cosmetics brands, medical aesthetics clinics, and pharmaceutical CDMO customers across global markets.

Ownership category

akta.pro rank

Product category

Cosmetic Raw Material Ingredients

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Biological Products, (No Disgnostic Substances) (2836), Services-Commercial Physical & Biological Research (8731), Medicinal Chemicals & Botanical Products (2833)

akta.pro industry

PRIMARYHLAIACAL

Dermatology Specialty Pharmaceuticals

Healthcare & Life Sciences/Pharmaceuticals/Specialty Pharmaceuticals

SECONDARYHLAAAKAC

Cell Therapy Manufacturing Services (GMP, autologous/allogeneic)

Healthcare & Life Sciences/Biotechnology & Biologics/Biomanufacturing Services

SECONDARYHLAGAGAG

Fill-Finish & Aseptic Drug Product Manufacturing (Biologics/ATMP)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)

SECONDARYHLAGAGAL

GMP Quality, Validation & Regulatory Support (GMP/CSV/Qualification)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)

SECONDARYHLAIAAAK

Dermatology & Aesthetics Pharmaceuticals

Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

• Exosome raw materials
• Cosmetic ingredient manufacturing
• Stem cell biotechnology
• Skincare OEM services
• Regenerative medicine research

Headquarters

HQ city

Taipei City

HQ country

Taiwan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Exosome Raw Material Sales (ExoGiov®): Sale of ExoGiov® Bio-Pulsed Exosome as a cosmetic raw material ingredient to cosmetics brands and manufacturers. ExoGiov® is registered under INCI and legally compliant for use in cosmetics across most international markets. Sold in lyophilized powder, liquid solution, and formulations.
2. OEM/ODM Manufacturing Services: Professional contract manufacturing services for exosome-derived cosmetic and skincare products. AM Biotech offers proven product formulations (essence, wrinkle cream, hair nourishing serum, mask, etc.) to customers seeking to develop exosome-based products. Reduces customer cost and time in new product development.
3. LA EXO® Consumer Skincare Products: Sale of finished consumer skincare and haircare products under the LA EXO® brand. Products include essence, anti-wrinkle cream, mask, and hair care serum. Distributed through LA EXO's own e-commerce website and the MOMO Shopping Network in Taiwan.
4. CDMO Manufacturing for Pharmaceutical Applications: Contract development and manufacturing services for exosome-based pharmaceutical and medical material products. The company is expanding into regenerative medicine fields including gynecology, dentistry, ophthalmology, nephrology, orthopedics, otolaryngology, and wound healing. Animal trials are finalized for most applications.
5. R&D Cooperation Services: Integrated solutions for exosome research including qualitative/quantitative analysis, particle size analysis, ultra-high purity extraction, and efficacy analysis for research institutions and companies with exosome research needs.

Go-to-market motion1 record

Distribution channels6 records

Marketing channels6 records

Core offering

AM Biotech develops, manufactures, and commercializes patented Bio-Pulsed stem cell-derived exosomes (ExoGiov®) as cosmetic raw material ingredients for skincare and haircare applications, sold in lyophilized powder and liquid forms to cosmetics brands and contract manufacturing partners worldwide. The company also provides OEM/ODM manufacturing services for exosome-based finished products, R&D cooperation services for exosome analysis, and CDMO services for pharmaceutical applications. A secondary consumer line (LA EXO®) of finished skincare and haircare products is sold through its own e-commerce platform and MOMO Shopping Network in Taiwan.

Product overview

AM Biotech is a biotechnology company specializing in patented Bio-Pulsed exosome technology for medical and cosmetic applications. The company operates with ExoGiov® Bio-Pulsed Exosome as the core raw material ingredient, which is sold to cosmetic manufacturers for inclusion in skincare and haircare products. Consumer-facing products are sold under the LA EXO® brand. The company offers OEM/ODM manufacturing services and R&D cooperation services, and has recently expanded into pharmaceutical CDMO services through partnership with PITDC. Their technology platform enables the production of induced exosomes with enhanced efficacy for skin repair, anti-aging, whitening, wound healing, and hair growth.

Differentiator

Problem solved

Functional benefit

Brands

• ExoGiov: Bio-Pulsed Aesthetic Exosome - A patented cosmetic raw material for skin rejuvenation and hair growth, derived from chicken embryonic mesenchymal stem cells.
• LA EXO
• MOMO

Products and services

• ExoGiov® Bio-Pulsed Exosome (raw material) Patented Bio-Pulsed Exosome cosmetic raw material derived from SPF chicken embryonic mesenchymal cells (INCI name: Chicken Embryonic Mesenchymal Cell-Derived Extracellular Vesicles), supplied in lyophilized powder, liquid solution, and formulation formats to cosmetics brands and manufacturers for use in skin rejuvenation, anti-aging, whitening, wrinkle reduction, wound healing, and hair growth product formulations.
• LA EXO® Exosome High-Efficiency Revitalization Series End-consumer skincare and haircare product line under the LA EXO® brand, including essence, anti-wrinkle cream, facial mask, and hair care serum, developed using ExoGiov bio-pulsed exosome technology for skin whitening, fine line smoothing, skin repair, and hair root strengthening applications. Sold through LA EXO's own e-commerce website and the MOMO Shopping Network in Taiwan.
• OEM/ODM Manufacturing Services Contract manufacturing services for exosome-derived cosmetic and skincare products, providing proven product formulations including essence, wrinkle cream, hair nourishing serum, and mask. Reduces customer R&D cost and time to market for cosmetics brands seeking to develop exosome-based products.
• R&D Cooperation Services Integrated exosome research services for academic and commercial partners, including qualitative and quantitative analysis, particle size analysis, ultra-high purity extraction, and efficacy analysis for research institutions and companies with exosome research needs.
• CDMO Manufacturing Services for Pharmaceutical Applications Contract development and manufacturing organization (CDMO) services for biotech and pharmaceutical products utilizing bio-pulsed exosome technology, covering regenerative medicine applications in gynecology, dentistry, ophthalmology, nephrology, orthopedics, otolaryngology, and wound healing. Partnering with PITDC for pharmaceutical product development and regulatory compliance.

Quantifiable outcome

• Type I collagen expression boosted by up to 250% in human skin fibroblasts
• +12 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Taiwan External Trade Development Council (TAITRA) - Taiwan Great Health Exhibition CentrecoreChannel Partner/ Reseller/ Distributor · 24 June 2025AM Biotech established presence at the Taiwan Great Health Exhibition Centre at MATRADE Exhibition and Convention Centre in Kuala Lumpur, Malaysia, established by TAITRA under the commission of the International Trade Administration, Ministry of Economic Affairs, Taiwan. The center showcases innovative technologies from 12 leading Taiwanese enterprises in AI smart healthcare, advanced medical devices, professional medical services, and aesthetic medicine. AM Biotech features its full range of patented Bio-Pulsed Exosome products ExoGiov® for the Malaysian and ASEAN market.
• SGS International (Third-Party Testing)minorOthers · 15 December 2024Independent third-party testing conducted by SGS confirmed the efficacy of AM Biotech's Patented Bio-Pulsed Technology. Results showed 100% of participants experienced increased collagen levels and more even skin tone, while 97% reported increased hair density and stronger hair roots. SGS testing covered cytotoxicity, heavy metals, skin sensitization (OECD TG 442C), eye irritation (OECD TG 492), skin irritation (OECD TG 439), microbial tests, and mold and yeast testing.
• Medical and Pharmaceutical Industry Technology and Development Center (PITDC)coreStrategic or Co-development Partner · 30 August 2024AM Biotech formed a partnership with PITDC through a 'Pharmaceutical Project Cooperation Development Agreement' on August 30, 2024, marking the official launch of multiple biotech and pharmaceutical development projects as the company ventures into the trillion-dollar pharmaceutical market. PITDC, renowned for pharmaceutical development and regulatory affairs expertise, will collaborate closely with AM Biotech on pharmaceutical initiatives. Development proceeds in two stages aimed at maximizing benefits of domestically produced high-value pharmaceutical products. The partnership addresses both domestic and international regulations, enhances quality management systems, and implements manufacturing technologies to reduce development risks and shorten time to market.
• Emosoxe Biotech International L.L.C. (USA)coreOEM/ Whitelabel/ Licensing Partner · 18 January 2024AM Biotech announced a collaboration with Emosoxe Biotech International L.L.C. from the United States to jointly develop the new generation LAEXO series of bio-pulsed skincare products, including essence, anti-wrinkle cream, mask, and hair care serum. Emosoxe assists in product development for the American market. The partnership represents AM Biotech's entry into the US market with international brand direction using English packaging and upgraded exosome concentration and formula designs meeting international high standards.
• Tri-Service General Hospital (National Defense Medical Center, Taiwan)coreStrategic or Co-development Partner · 10 January 2023AM Biotech and Tri-Service General Hospital discussed and initiated collaboration on preclinical research and clinical trials of biochemical pulse extracellular vesicles. The hospital conducted IRB (Institutional Review Board) human cell efficacy testing for ExoGiov, with results co-published in the International Journal of Molecular Sciences. Clinical trials for skin and hair growth applications are being conducted at the hospital. The collaboration also explores applications in premature ovarian failure, degenerative arthritis, macular degeneration, special trauma, post-cancer treatment repair, periodontitis, alveolar bone repair, ischemic stroke, and hearing loss treatment.

Scale indicators11 records

Recent moves8 records

Expansion highlights5 records

Market position

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/am-biotech-ascension-medical-biotechnology

Compliance11 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AM BioTech - Ascension Medical Biotechnology